Historically, clinical genomics has been driven by a phenotype-first approach. However, many genomic conditions remain under-diagnosed due to both potential under-ascertainment and challenges in accessing expert care and testing. The Geisinger MyCode Community Health Initiative, an unselected healthcare-based population with >170,000 patient-participants with exome sequencing and linked electronic health records (EHR), is uniquely positioned to pursue a genotype-first approach to disease diagnosis to expand our understanding of the penetrance, phenotypic spectrum, and progression of genomic conditions.